 "Noisy knees? Arthritis may be in your future")
Come May, the world’s first multi-centre phase-3 clinical trial to examine the efficacy of ayurvedic treatment for rheumatoid arthritis will begin in India.
The 240-volunteer trial would be conducted across three cities in India – Coimbatore, Bengaluru and Mumbai--in accordance with International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use – Good Clinical Practice (ICH-GCP) guidelines.
In a statement, the Ayush Ministry said on Wednesday that the trial will be closely monitored by Daniel Erick Furst, rheumatologist at University of California, Los Angeles.
“This project is one of the first multi-centre phase III double-blind double-dummy clinical trials on the efficacy
